Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K024218
    Manufacturer
    Date Cleared
    2003-01-17

    (25 days)

    Product Code
    Regulation Number
    866.5100
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    LIQUICHEK ANTI-SS-A CONTROL, POSITIVE, CATALOG #114

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Liquichek Anti-SS-A Control, Positive, is intended for use as an unassayed quality control to monitor indirect immunofluorescent testing for the detection of SS-A autoantibodies.

    Device Description

    This product is prepared from human serum with added preservatives. The control is provided in liquid form for convenience.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and the study information for the Liquichek™ Anti-SS-A Control, Positive, based on the provided document:

    This document describes a quality control product, not a diagnostic device that directly assesses patient conditions. Therefore, the typical "performance" metrics for a diagnostic device (e.g., sensitivity, specificity, AUC) are not applicable. Instead, the acceptance criteria relate to the stability and consistency of the control material.

    Acceptance Criteria and Reported Device Performance

    Acceptance CriteriaReported Device Performance
    Open Vial StabilityAnalyte stable for 60 days when stored tightly capped at 2-8°C after opening.
    Shelf Life (Unopened)Control is stable for 2 years when stored unopened at 2-8°C.

    Study Details:

    Based on the provided document, the study conducted is a stability study.

    1. Sample size used for the test set and the data provenance:

    • Test Set Sample Size: Not explicitly stated. The document refers to "supporting data" and "real time studies" but doesn't provide specific sample numbers of control vials tested.
    • Data Provenance: Not explicitly stated regarding country of origin. The study is described as "Real-time studies will be ongoing," which suggests a prospective study design for shelf life, and the open vial stability would also be prospective. All data is retained by Bio-Rad Laboratories.

    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • Not applicable directly. This is a quality control product, not a diagnostic device requiring expert interpretation for ground truth. The "ground truth" here is the inherent stability of the control material over time, measured through established laboratory assays.

    3. Adjudication method for the test set:

    • Not applicable as there's no diagnostic interpretation requiring adjudication.

    4. If a multi-reader, multi-case (MRMC) comparative effectiveness study was done:

    • No, an MRMC study was not done. This type of study is for evaluating observer performance with and without an assist device for diagnostic tasks.

    5. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

    • Not applicable. This is not an algorithm-based device.

    6. The type of ground truth used:

    • The ground truth for this device's performance is the measured stability of the Anti-SS-A analyte within the control material over defined time periods (60 days open, 2 years unopened) when subjected to specific storage conditions. This would be determined by repeatedly testing the control material using accepted laboratory methods for Anti-SS-A detection and ensuring the results remain within a predefined acceptable range.

    7. The sample size for the training set:

    • Not applicable. This is a quality control product undergoing stability testing, not a machine learning algorithm that requires a training set.

    8. How the ground truth for the training set was established:

    • Not applicable. (See #7).
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1